Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

DSNKY DAIICHI SANKYO COMPANY LIMITED SPON ADR EA REPR 1 ORD JPY0.00 LEVEL I

28.060
+0.210+0.75%
Close 09/30 16:00 ET
28.250
+0.190+0.68%
Post Mkt Price 09/30 16:01 ET
High
28.450
Open
27.500
Turnover
3.33M
Low
27.500
Pre Close
27.850
Volume
117.80K
Market Cap
53.79B
P/E(TTM)
144.64
52wk High
32.350
Shares
1.92B
P/E(Static)
97.77
52wk Low
19.390
Float Cap
53.79B
Bid/Ask %
0.00%
Historical High
32.350
Shs Float
1.92B
Volume Ratio
1.41
Historical Low
18.050
Dividend TTM
0.188
Div Yield TTM
0.209
P/B
5.55
Dividend LFY
0.67%
Div Yield LFY
0.74%
Turnover Ratio
0.01%
Amplitude
3.41%
Avg Price
28.252
Lot Size
1
Float Cap
53.79B
Bid/Ask %
0.00%
Historical High
32.350
Shs Float
1.92B
Volume Ratio
1.41
Historical Low
18.050
Dividend TTM
0.188
P/B
5.55
Dividend LFY
0.67%
Turnover Ratio
0.01%
Amplitude
3.41%
Avg Price
28.252
Lot Size
1
Price Forecast

No Data

News

Comment

No Data

Company Overview More
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
CEO: Mr. Sunao Manabe
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...